Article: Lawsuit could block peanut allergy drug.

DENVER, Mar 10, 2003 (United Press International via COMTEX)

A legal squabble among companies making drugs that might prevent peanut food allergy incidents has halted large-scale studies of the medications, researchers said Monday.

Dr. Hugh Sampson, professor of pediatrics at the Mount Sinai School of Medicine in New York, said investigators earlier this year were ready to begin a large study of the drug TNX-901, which showed effectiveness in preventing life-threatening peanut allergy reactions. But because of the legal dispute over competing drugs those studies have been stalled indefinitely.

"About 125 deaths occur in the United States each ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!